Nextage Therapeutics Financials

MCTC Stock  ILA 37.70  1.30  3.33%   
Financial data analysis helps to check out if markets are presently mispricing Nextage Therapeutics. We were able to interpolate thirty-one available fundamentals for Nextage Therapeutics, which can be compared to its peers in the industry. To ensure the equity is not overpriced, please verify all Nextage Therapeutics financials, including its ebitda, cash and equivalents, debt to equity, as well as the relationship between the net income and cash per share . The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Nextage Therapeutics to be traded at 36.19 in 90 days.
With this module, you can analyze Nextage financials for your investing period. You should be able to track the changes in Nextage Therapeutics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Nextage Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nextage Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Nextage Therapeutics' assets may result in an increase in income on the income statement.
Evaluating Nextage Therapeutics' financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Nextage Therapeutics' profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Nextage Therapeutics' relative financial performance

Chance Of Distress

Over 82

 
100  
 
Zero
Very High
Nextage Therapeutics has more than 82 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Nextage Therapeutics stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Nextage Therapeutics' odds of distress score SHOULD NOT be confused with the real chance of Nextage Therapeutics filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Nextage is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Nextage Therapeutics' liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Nextage Therapeutics' official financial statements usually reflect Nextage Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nextage Therapeutics. For example, before you start analyzing numbers published by Nextage accountants, it's critical to develop an understanding of what Nextage Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Nextage Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nextage Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nextage Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nextage Therapeutics. Please utilize our Beneish M Score to check the likelihood of Nextage Therapeutics' management manipulating its earnings.

Nextage Therapeutics Company Summary

Nextage Therapeutics competes with Bank Leumi, Mizrahi Tefahot, Norstar, Gazit Globe, and Alony Hetz. Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.
Foreign Associate
  USA
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
ISINIL0004330119
Business AddressBuilding 7, Entrance
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.m-medic.com
Phone972 73 2753450
CurrencyILA
You should never invest in Nextage Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nextage Stock, because this is throwing your money away. Analyzing the key information contained in Nextage Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Nextage Therapeutics Key Financial Ratios

Generally speaking, Nextage Therapeutics' financial ratios allow both analysts and investors to convert raw data from Nextage Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Nextage Therapeutics over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nextage Therapeutics reports annually and quarterly.

Nextage Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nextage Therapeutics's current stock value. Our valuation model uses many indicators to compare Nextage Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nextage Therapeutics competition to find correlations between indicators driving Nextage Therapeutics's intrinsic value. More Info.
Nextage Therapeutics is considered to be number one stock in current asset category among related companies. It is considered to be number one stock in retained earnings category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nextage Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nextage Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nextage Therapeutics' earnings, one of the primary drivers of an investment's value.

Nextage Therapeutics Systematic Risk

Nextage Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nextage Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Nextage Therapeutics correlated with the market. If Beta is less than 0 Nextage Therapeutics generally moves in the opposite direction as compared to the market. If Nextage Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nextage Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nextage Therapeutics is generally in the same direction as the market. If Beta > 1 Nextage Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

About Nextage Therapeutics Financials

What exactly are Nextage Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Nextage Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Nextage Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Nextage Therapeutics investors may use each financial statement separately, they are all related. The changes in Nextage Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nextage Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Nextage Therapeutics Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Nextage Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Nextage has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Nextage Therapeutics' financials are consistent with your investment objective using the following steps:
  • Review Nextage Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Nextage Therapeutics' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Nextage Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Nextage Therapeutics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Nextage Therapeutics March 18, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Nextage Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nextage Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nextage Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Nextage Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nextage Therapeutics's daily price indicators and compare them against related drivers.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.